T2 Biosystems Inc (NASDAQ: TTOO) stock suffered a major decline of -10.5% on 1/24/24. The shares closed at $3.82. However, unusually low trading volume at 51% of normal accompanied the decline. Relative to the market the stock has been extremely weak over the last nine months and has declined -5.2% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, TTOO is expected to continue to be a major Value Eraser.
T2 Biosystems is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment